|
CN101163687A
|
|
Spiro-heterocyclic chromans, thiochromans and dihydroquinolines
|
|
EP1836183A2
|
|
Spiro derivatives as lipoxygenase inhibitors
|
|
AU2005328328A1
|
|
Spiro-heterocyclic chromans, thiochromans and dihydroquinolines
|
|
CA2580563A1
|
|
Benzofuran derivatives
|
|
WO2005032544A1
|
|
Treatment of mitochondrial diseases
|
|
WO2004045534A2
|
|
Chroman derivatives for the reduction of inflammation symptoms
|
|
US7078541B2
|
|
Benzofuran derivatives
|
|
AU2003247685A8
|
|
Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects
|
|
AU2003210904A2
|
|
Cytoprotective benzofuran derivatives
|
|
US6653346B1
|
|
Cytoprotective benzofuran derivatives
|
|
US6667330B2
|
|
Furanone derivatives
|
|
US7119117B2
|
|
Tocopherol enriched compositions and amelioration of inflammatory symptoms
|
|
US6608196B2
|
|
Process for solid supported synthesis of pyruvate-derived compounds
|
|
US6916850B2
|
|
Pyruvate derivatives
|
|
EP1360327A1
|
|
Method for identifying genes regulating desired cell phenotypes
|
|
US7034054B2
|
|
Methods for the prevention and treatment of cerebral ischemia using non-alpha tocopherols
|
